Alliances
Scientific collaboration to study the anti-inflammatory activity of gut beneficial bacteria, more specifically Christensenella for which LNC Therapeutics holds an exclusive worldwide license
Study will evaluate the safety and efficacy of the combination of iTeos’ EOS100850 and Merck’s KEYTRUDA® (pembrolizumab)
Start Codon cohort companies to receive One Nucleus membership benefits
Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities.
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
Under the terms of the deal, Scripps will run preclinical R&D, and in some cases, Phase I clinical trials. AbbVie will have an exclusive option to continue development and possible commercialization activities.
MC Services AG, a leading international public relations and investor relations firm, announced today that it will be, for the first time, a media partner for Biotech ShowcaseTM.
Although there have been numerous variations on CRISPR that improve its effectiveness and apparent safety, there are still concerns about off-target edits and immune reactions to the Cas9 enzyme used to cut DNA.
Boston Biomedical announced it had launched an oncology research alliance with Columbia University, Harvard University and The Wistar Institute.
Owkin, which is developing Federated Learning and AI technologies to advance medical research, announces it is teaming up with technology company NVIDIA and King’s College London to deliver Federated Learning in the healthcare and life sciences sector.
Agreement strengthens collaboration between the companies following submission of the first dossier to the European Medicines Agency (EMA) for a CrisBio® produced recombinant vaccine
PRESS RELEASES